IMARC Group, a leading market research company, has recently releases report titled “Anatomic Pathology Market Report by Product and Services (Instruments, Consumables, Services), Application (Disease Diagnosis, Drug Discovery and Development, and Others), End User (Hospitals, Research Laboratories, Diagnostic Laboratories, and Others), and Region 2025-2033” The study provides a detailed analysis of the industry, including the global anatomic pathology market trends, share, size and growth forecast. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
Report Highlights:
How Big Is the Anatomic Pathology Market?
The global anatomic pathology market size reached USD 41.3 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 77.6 Billion by 2033, exhibiting a growth rate (CAGR) of 6.92% during 2025-2033. The market is experiencing steady growth driven by the increasing prevalence of cancer, continuous technological advancements in the healthcare industry, and the integration of molecular techniques, particularly in companion diagnostics, which is shaping the future of personalized medicine.
Global Anatomic Pathology Market Trends:
The heightened collaboration between academic institutions and industry players to drive research and development (R&D) in molecular pathology is anticipated to drive the market growth. Moreover, rapid innovations in molecular diagnostics that enable the identification of specific genetic markers and molecular events associated with diseases, leading to tailored treatment strategies, are contributing to the market growth. Furthermore, the growing trend toward the adoption of companion diagnostics, which involves pairing molecular diagnostic tests with specific therapeutic agents to enhance treatment efficacy and safety, is bolstering the market growth.
Factors Affecting the Growth of the Anatomic Pathology Industry:
Increasing Prevalence of Chronic Diseases:
The heightened prevalence of chronic diseases across the globe, including cancer, cardiovascular disorders, and diabetes, is a major factor catalyzing the market growth. In line with this, the growing need for prolonged care and routine monitoring in chronic diseases that employ anatomic pathology for diagnosis and management is favoring the market growth. Moreover, the rising focus of healthcare systems on accurate diagnostic tools like histopathology and cytology, which are subsets of anatomic pathology as chronic diseases require precise and timely diagnosis for effective treatment, is acting as a growth-inducing factor. Additionally, the burgeoning geriatric population, who are more susceptible to health conditions, is driving the market growth.
Rapid Technological Advancements in Diagnostic Techniques:
The rising technological advancements in diagnostic techniques that enhance the capabilities and efficiency of anatomic pathology services are positively impacting the market growth. Moreover, the introduction of digital pathology, which involves the digitization of pathology slides for easier access, analysis, and storage to facilitate faster diagnosis and enhanced accuracy, is anticipated to drive the market growth. Additionally, the burgeoning integration of artificial intelligence (AI) and machine learning (ML) technologies, enabling pathologists to detect abnormalities with greater accuracy and speed, is bolstering the market growth. They improve patient outcomes through timely and accurate disease diagnosis and significantly reduce the workload of pathologists by automating routine tasks.
Expansion of Healthcare Infrastructure and Increasing Healthcare Expenditure:
The widespread expansion of healthcare infrastructure and the corresponding rise in healthcare expenditure are crucial factors propelling the market growth. Moreover, the growing emphasis on including sophisticated diagnostic services, such as anatomic pathology, as countries develop and enhance their healthcare systems, is positively impacting the market growth. Additionally, the rising healthcare expenditure in countries across the globe, fueled by governmental and private investments, is providing a considerable boost to the market growth. Besides this, the rising adoption of advanced diagnostic technologies that aid in the establishment of specialized pathology labs and training of medical personnel is anticipated to drive the market growth.
Request for a sample copy of this report: https://www.imarcgroup.com/anatomic-pathology-market/requestsample
Anatomic Pathology Market Report Segmentation:
By Product and Services:
- Instruments
- Microtomes and Cryostat
- Tissue Processors
- Automatic Stainer
- Whole Slide Imaging (WSI) Scanners
- Others
- Consumables
- Reagents and Antibodies
- Probes and Kits
- Others
- Services
Consumables accounted for the largest market share due to their recurring need and essential role in daily pathological assessments and testing procedures.
By Application:
- Disease Diagnosis
- Drug Discovery and Development
- Others
Disease diagnosis represented the largest segment as the primary utility of anatomic pathology is to identify and confirm diseases, which is fundamental to patient management and treatment decisions.
By End User:
- Hospitals
- Research Laboratories
- Diagnostic Laboratories
- Others
Hospitals constituted the largest segment as they house major diagnostic facilities and cater to a large volume of patients that require diverse diagnostic services, including anatomic pathology.
Regional Insights:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
North America's dominance in the anatomic pathology market is attributed to advanced healthcare infrastructure, high healthcare spending, and the early adoption of novel diagnostic technologies.
Who are the key players operating in the industry?
The report covers the major market players including:
- Agilent Technologies Inc.
- Ameripath (Quest Diagnostics Incorporated)
- BioGenex
- Cardinal Health
- Epredia (PHC Holdings Corporation)
- F. Hoffmann-La Roche Ltd
- Laboratory Corporation of America Holdings
- Leica Biosystems Nussloch GmbH (Danaher Corporation)
- NeoGenomics Laboratories Inc.
- Sakura Finetek USA, Inc. (Olympus Corporation)
Ask Analyst: https://www.imarcgroup.com/request?type=report&id=19324&flag=C
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
About Us:
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services.
IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.
Contact US:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145
